0001773751-23-000323.txt : 20231229
0001773751-23-000323.hdr.sgml : 20231229
20231229180906
ACCESSION NUMBER: 0001773751-23-000323
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231227
FILED AS OF DATE: 20231229
DATE AS OF CHANGE: 20231229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dudum Andrew
CENTRAL INDEX KEY: 0001837796
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38986
FILM NUMBER: 231528954
MAIL ADDRESS:
STREET 1: 2269 CHESTNUT STREET, #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hims & Hers Health, Inc.
CENTRAL INDEX KEY: 0001773751
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2269 CHESTNUT ST
STREET 2: #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
BUSINESS PHONE: 415-851-0195
MAIL ADDRESS:
STREET 1: 2269 CHESTNUT ST
STREET 2: #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
FORMER COMPANY:
FORMER CONFORMED NAME: Oaktree Acquisition Corp.
DATE OF NAME CHANGE: 20190412
4
1
wk-form4_1703891337.xml
FORM 4
X0508
4
2023-12-27
0
0001773751
Hims & Hers Health, Inc.
HIMS
0001837796
Dudum Andrew
2269 CHESTNUT STREET, #523
SAN FRANCISCO
CA
94123
1
1
1
0
Chief Executive Officer
1
Class A Common Stock
2023-12-27
4
M
0
7700
2.43
A
59353
D
Class A Common Stock
2023-12-27
4
S
0
7700
9.0211
D
51653
D
Class A Common Stock
2023-12-28
4
M
0
25750
2.43
A
77403
D
Class A Common Stock
2023-12-28
4
S
0
25750
9.0098
D
51653
D
Class A Common Stock
2023-12-29
4
M
0
21432
2.43
A
73085
D
Class A Common Stock
2023-12-29
4
S
0
21432
9.0623
D
51653
D
Class A Common Stock
1315881
I
Held by Trustee of AD 2022 GRAT 3
Class A Common Stock
1743758
I
Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
Class A Common Stock
1675943
I
Held by Trustee of AD 2021 GRAT dated 11-1-2021
Class A Common Stock
597335
I
Held by Trustee of AD 2022 GRAT
Class A Common Stock
570398
I
Held by Trustee of Dudum Family Community Property Trust
Class A Common Stock
418986
I
Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
Class A Common Stock
1584506
I
Held by Trustee of AD 2023 GRAT dated 9-5-2023
Class A Common Stock
891735
I
Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
Class A Common Stock
1500
I
Held by Trustees of Richard M. Dudum Irrevocable 1 U/A dtd 10/15/1997
Class A Common Stock
2874769
I
Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021
Stock Option (right to buy)
2.43
2023-12-27
4
M
0
7700
0
D
2030-06-17
Class A Common Stock
7700
2980064
D
Stock Option (right to buy)
2.43
2023-12-28
4
M
0
25750
0
D
2030-06-17
Class A Common Stock
25750
2954314
D
Stock Option (right to buy)
2.43
2023-12-29
4
M
0
21432
0
D
2030-06-17
Class A Common Stock
21432
2932882
D
The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.075. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.035. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.01 - $9.12. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.
/s/ Kimberly Mather, Attorney-in-Fact
2023-12-29